Saturday, December 28, 2013

Comment Regarding Office Use under DQSA: 503A v. 503B--Are State Boards of Pharmacy Paying Attention!

1 comment:

Kenneth Woliner, MD said...
So, as I read this, any physician (or hospital) who wants to obtain compounded medications for "office use" (i.e. - no patient-specific prescription before the drug is ordered) - needs to buy it from an OUTSOURCING FACILITY. No if's and's or but's.

I hope state boards of medicine and boards of pharmacy are listening.

Kenneth Woliner, MD
www.holisticfamilymed.com

-------
Q: Under the new law, does a pharmacy wishing to compound a sterile non-patient specific product have to register under 503B?
A: Exact quote from Jane Axelrad:
“Section 503A was not changed by the new law and patient specific prescriptions are required under Section 503A. As you know, as you observe, 503B provides a pathway in which hospitals and health care professionals can purchase compounded drugs without prescriptions.”
Q: Only under 503B can you provide non-patient specific product?
A: Exact quote from Jane Axelrad: “If you want to qualify for the exemption under 503A.”

Florida DOH v. John Foster, MD (solutions pharmacy acted as an unlicensed wholesaler for compounded SottoPelle BHRT pellets)


The doctor only got a "letter of concern" and a $5,000 fine. 


1  record(s) found.
NameLicenseProfessionCityStateCase #Action Taken
FOSTER, JOHN DAVID42368Medical DoctorATLANTIC BEACHFL201010461Obligation(s) Satisfied
Thank you to Dr. Kenneth Woliner for the research and information.